The Retinal Biologics market is a subset of the larger Biotechnology industry. It focuses on the development of treatments for retinal diseases, such as age-related macular degeneration, diabetic retinopathy, and retinal vein occlusion. These treatments are typically delivered through injections, implants, or other delivery systems. The goal of these treatments is to improve vision and reduce the risk of vision loss. The Retinal Biologics market is highly competitive, with many companies developing innovative treatments. Companies in this market include Regeneron Pharmaceuticals, Allergan, Novartis, Genentech, and Roche. These companies are actively researching and developing treatments for retinal diseases, with the goal of improving patient outcomes. Show Less Read more
ASK A QUESTION
We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.
